To our knowledge, the current study, which investigated some selected transcripts extracted from the nasal cavity fluid cells of PD patients and age-matched controls, was the first to report that parkin and AIMP2 mRNA levels could serve as potential biomarkers for the diagnosis of PD. Here, PRKN is linked to Parkinson disease.